CorVel (NASDAQ:CRVL) Releases Earnings Results

CorVel (NASDAQ:CRVL) posted its earnings results on Tuesday. The business services provider reported $0.46 EPS for the quarter, Zacks reports. CorVel had a return on equity of 31.73% and a net margin of 9.64%.

CorVel Stock Performance

CRVL stock opened at $117.58 on Tuesday. The company has a 50 day moving average price of $123.76 and a two-hundred day moving average price of $111.79. The stock has a market capitalization of $6.00 billion, a P/E ratio of 75.64 and a beta of 1.16. CorVel has a one year low of $76.20 and a one year high of $127.24.

Analyst Ratings Changes

Separately, StockNews.com downgraded shares of CorVel from a “buy” rating to a “hold” rating in a report on Friday, January 3rd.

Insider Transactions at CorVel

In other CorVel news, EVP Mark E. Bertels sold 1,050 shares of CorVel stock in a transaction that occurred on Thursday, December 5th. The shares were sold at an average price of $119.12, for a total transaction of $125,072.50. Following the transaction, the executive vice president now directly owns 2,580 shares of the company’s stock, valued at $307,321. The trade was a 28.93 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders own 47.57% of the company’s stock.

About CorVel

CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.